Output details
12 - Aeronautical, Mechanical, Chemical and Manufacturing Engineering
Imperial College London
A quantitative atlas of histone modification signatures from human cancer cells
This article presents a holistic and proteomic characterisation of histone post-translational modifications (PTMs) across 24 cancer cell lines, which was referenced by Biome as ‘a helpful resource for the community to further analyse and classify cancer cells’ (http://www.biomedcentral.com/biome/cancer-mapped-an-atlas-of-histone-modifications-across-cancer-cell-lines/). The LC-MS/MS workflow utilised in this article for quantitatively profiling histone PTMs is being translated to identify therapeutic targets with Pfizer-Neusentis (Dr. Rachel Grimley; Epigenetics Exploratory Lead) and has resulted in a joint Pfizer-Neusentis and Institute for Chemical Biology (ICB)-funded PhD studentship award (http://www.icb-cdt.co.uk/research/projects/profiling-the-methylome-targets-of-histone-lysine-methyltransferases).